What laboratory evaluations and monitoring are recommended for a newborn with congenital hypothyroidism?

Laboratory Evaluation and Monitoring for Newborn Congenital Hypothyroidism

Initial Screening

All newborns should undergo screening for congenital hypothyroidism, ideally at 48-72 hours of age using either TSH-based or T4-based methods, with TSH being the most common primary screening marker worldwide. 1

• Screen TSH > 20 mIU/L (serum units) warrants immediate recall for confirmatory testing 2
• Screen TSH > 34 mIU/L for samples taken between 24-48 hours requires recall 2
• Screen TSH > 40 mIU/L necessitates immediate venous confirmatory testing with T4/FT4 and TSH 2
• For milder TSH elevations, obtain a second screening TSH at 7-10 days of age 2

Confirmatory Laboratory Testing

When screening is positive, confirmatory venous blood testing must include both TSH and T4 or free T4 (FT4) to distinguish true disease from false positives. 3, 4

Diagnostic Thresholds for Primary CH:

• Venous TSH > 20 mIU/L before age 2 weeks with low T4 (<10 μg/dL) or FT4 (<1.17 ng/dL) confirms primary CH 2
• Venous TSH > 10 mIU/L after age 2 weeks with low T4/FT4 confirms primary CH 2
• Consistently abnormal analyte levels on repeat testing can be diagnostic for congenital hypothyroidism 3

Monitoring Schedule During Treatment

Monthly monitoring is required throughout the first 6 months of life, with more than one-third of infants requiring monthly monitoring between 6-12 months based on laboratory outcomes. 5

First Year Monitoring Protocol:

• At 2 weeks after treatment initiation: Measure serum T4 or FT4 only 2
• At 1 month: Measure both TSH and T4/FT4 2
• Months 1-6: Monitor every 1-2 months 6
• Months 6-12: Monitor every 2 months 2
• Infants with higher baseline TSH and lower T4 at diagnosis are more likely to require monthly monitoring in the second 6 months 5

Beyond First Year:

• Ages 1-3 years: Monitor every 3 months 2, 6
• After age 3 years: Monitor every 3-6 months 2

Treatment Goals and Target Ranges

The primary laboratory goal is maintaining T4/FT4 in the upper half of the age-specific reference range with rapid TSH normalization, particularly during the first 3 years when brain development is most thyroid hormone-dependent. 4, 6

• Target serum T4/FT4 levels appear higher in the first two weeks of treatment 6
• TSH should normalize within 2 weeks when adequate dosing (12-17 mcg/kg/day) is used 6
• Approximately 30% of children have at least one high TSH level with T4/FT4 not in the upper half of normal range during the first year, highlighting the need for frequent monitoring 5

Special Populations

Preterm and Low Birth Weight Infants:

• Screen at 48-72 hours postnatal age 2
• Sick neonates should be screened by at least 7 days of age 2

Re-evaluation for Transient CH:

• Infants with suspected transient congenital hypothyroidism should undergo re-evaluation at age 3 years to determine if lifelong therapy is necessary 2

Critical Pitfall

Clinical symptoms of hypothyroidism (large posterior fontanelle, large tongue, umbilical hernia, prolonged jaundice, constipation, lethargy, hypothermia) warrant immediate thyroid function testing regardless of normal newborn screening results. 4 Newborn screening alone is insufficient to prevent all adverse outcomes, and physicians must maintain clinical vigilance even with negative screening 4.